Sutro Biopharma (STRO) EPS (Basic) (2017 - 2025)
Sutro Biopharma (STRO) reported EPS (Basic) of -$5.5 for Q4 2025, up 41.65% on a YoY basis from -$3.88 in Q4 2024, and up 17.87% sequentially from -$6.7 in Q3 2025.
Sutro Biopharma (STRO) EPS (Basic) (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of EPS (Basic) data on file, last reported at -$5.5 in Q4 2025.
- For the quarter ending Q4 2025, EPS (Basic) rose 41.65% year-over-year to -$5.5; the trailing twelve-month figure through Dec 2025 stood at -$21.5 (up 27.37% YoY), and the FY2025 full-year result was -$22.49, up 24.05% from the prior year.
- EPS (Basic) rose to -$5.5 in Q4 2025, from -$6.7 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $5.16 in Q4 2023 to a low of -$9.47 in Q1 2024.
- A 5-year average of -$5.77 and a median of -$6.54 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) plunged 315.25% in 2022 and soared 175.71% in 2023, its largest moves.
- Tracing STRO's EPS (Basic) over 5 years: stood at -$8.27 in 2021, then increased by 17.52% to -$6.82 in 2022, then soared by 175.71% to $5.16 in 2023, then plunged by 282.66% to -$9.43 in 2024, then soared by 41.65% to -$5.5 in 2025.
- Business Quant data shows STRO's EPS (Basic) at -$5.5 in Q4 2025, -$6.7 in Q3 2025, and -$1.36 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - | -5.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.50 |
| Sep 30, 2025 | -6.70 |
| Jun 30, 2025 | -1.36 |
| Mar 31, 2025 | -8.14 |
| Dec 31, 2024 | -9.43 |
| Sep 30, 2024 | -5.95 |
| Jun 30, 2024 | -5.91 |
| Mar 31, 2024 | -9.47 |
| Dec 31, 2023 | 5.16 |
| Sep 30, 2023 | -8.13 |
| Jun 30, 2023 | -6.38 |
| Mar 31, 2023 | -8.52 |
| Dec 31, 2022 | -6.82 |
| Sep 30, 2022 | -3.72 |
| Jun 30, 2022 | -5.54 |
| Mar 31, 2022 | -8.41 |
| Dec 31, 2021 | -8.27 |
| Sep 30, 2021 | -6.69 |
| Jun 30, 2021 | -1.33 |
| Mar 31, 2021 | -4.28 |